Immune-Related Trafficking and Signaling in Human Skin Associated With Low-Power, Infrared Laser Treatment

Completed · Not applicable

Conditions studied: Vaccine Response Impaired

In brief

The purpose of this is that the researcher can use low power Near Infrared laser treatment non-painful and non-damaging dose to changes the skin properties.The researcher can prove that signaling and a significant increase in the number of skin cells in skin tissue exposed to the laser can improve the human skin immune system to help improve human body response to vaccines.

Key facts

Study ID

NCT02453113

Run by

University of California, Irvine

People needed

10

Starts

2015-06-01

Expected to finish

2019-01-01

Last updated by the study team

2022-11-01

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult men and women with skin type 1 and 2
• Not pregnant

You may not qualify if…

• Use of systemic steroids, topical steroids, tanning solutions and anticoagulant
• History of HIV, mentally incompetent, prisoner, alcohol or drug impairment
• Abnormal photosensitivity

Where it is running

• Beckman Laser Institute — Irvine, California, United States
• Vaccine and Immunotherapy Center Massachusetts General Hospital — Charlestown, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.